Document is current

Any future updates will be listed below

Post-marketing pharmacovigilance study of inclisiran: mining and analyzing adverse event data from the FDA Adverse Event Reporting System database

Crossref DOI link: https://doi.org/10.1007/s11096-024-01784-0

Published Online: 2024-08-27

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark